DB&C Advisors’s Amgen AMGN Stock Holding History

DB&C Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505K	Buy	1,394 +7	+0.5%	+$2.4K	0.55%	42
2026 Q1	$488K	Sell	1,387 -8	-0.6%	-$2.85K	0.63%	41
2025 Q4	$457K	Buy	+1,395	New	+$443K	0.57%	43

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

DB&C Advisors's AMGN Position: Q2 2026 in Review

DB&C Advisors increased its Amgen (AMGN) stake by 0.5% in Q2 2026, buying an estimated $2.4K and bringing the position to 1,394 shares worth $505K. The position accounts for 0.55% of the portfolio, ranked #42.

DB&C Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

DB&C Advisors held 1,394 shares of Amgen worth $505K as of Q2 2026.
DB&C Advisors bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
Amgen made up 0.55% of DB&C Advisors's portfolio in Q2 2026, its #42 holding.
DB&C Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DB&C Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.